{
    "2021-09-20": [
        [
            {
                "time": "2023-10-18",
                "original_text": "AbbVie (ABBV) Stock Moves -1.23%: What You Should Know",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "stock moves",
                        "-1.23%"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "AbbVie Submits Regulatory Application to FDA for Risankizumab-rzaa (SKYRIZIÂ®) for the Treatment of Patients 16 Years and Older with Moderate to Severe Crohn's Disease",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "FDA",
                        "Risankizumab-rzaa",
                        "SKYRIZI",
                        "Crohn's Disease"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}